Medicare Enrolled

Dr. Zdenka Segota, MD

Hematology & Oncology · Delray Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
6282 LINTON BLVD, Delray Beach, FL 33484
5619556229
In practice since 2006 (19 years)
NPI: 1619926110 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Segota from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Segota? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Segota

Dr. Zdenka Segota is a hematology & oncology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Segota performed 374 Medicare services across 296 unique beneficiaries.

Between the years covered by Open Payments, Dr. Segota received a total of $15,499 from 43 pharmaceutical and/or device companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Segota is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 374 Medicare services$ $15,499 industry payments

Medicare Practice Summary

Medicare Utilization ↗
374
Medicare services
Bottom 35% in FL for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
296
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity83$64$215
Office visit, established patient (20-29 min)79$45$237
Office visit, established patient, complex (40-54 min)56$108$465
New patient office visit (45-59 min)49$105$376
Initial hospital admission, moderate complexity44$106$397
Hospital follow-up visit, high complexity34$97$323
Initial hospital admission, high complexity18$141$588
Office visit, established patient (30-39 min)11$79$270
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,499
Total received (2018-2024)
Avg $2,214/year across 7 years
Top 30% in FL for hematology & oncology
43
Companies
234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,004 (58.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,168 (20.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,200 (14.2%)
Other
Charitable contributions, space rental, and other categories
$1,126 (7.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,528
2023
$2,117
2022
$339
2021
$775
2020
$3,152
2019
$1,262
2018
$4,325

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,601
PFIZER INC.
$3,421
Janssen Scientific Affairs, LLC
$2,143
NOVARTIS PHARMACEUTICALS CORPORATION
$1,809
Novartis Pharmaceuticals Corporation
$1,454
Astellas Pharma US Inc
$585
Janssen Biotech, Inc.
$293
Genentech USA, Inc.
$282
Lilly USA, LLC
$195
Eisai Inc.
$186
AbbVie Inc.
$182
Puma Biotechnology, Inc.
$157
Merck Sharp & Dohme Corporation
$82
Takeda Pharmaceuticals U.S.A., Inc.
$81
AbbVie, Inc.
$77
GENZYME CORPORATION
$77
Celgene Corporation
$64
Amgen Inc.
$64
Dova Pharmaceuticals
$58
Daiichi Sankyo Inc.
$57
E.R. Squibb & Sons, L.L.C.
$56
ABBVIE INC.
$52
EISAI INC.
$45
EMD Serono, Inc.
$44
Incyte Corporation
$41
Karyopharm Therapeutics Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$35
Adaptive Biotechnologies Corporation
$29
Alexion Pharmaceuticals, Inc.
$29
Janssen Pharmaceuticals, Inc
$25
Advanced Accelerator Applications
$25
Blue Earth Diagnostics Limited
$21
Sobi, Inc
$20
Alnylam Pharmaceuticals Inc.
$20
CSL Behring
$19
Mylan Institutional Inc.
$19
TerSera Therapeutics LLC
$19
TOLMAR Pharmaceuticals, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
Seattle Genetics, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
Agios Pharmaceuticals, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 59.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Afstyla · Avastin · Axumin · BOSULIF · CERDELGA · CHANTIX · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · EMEND · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Erleada · Fulphila · GAZYVA · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · Lutathera · NINLARO · Nerlynx · Nubeqa · ONPATTRO · ONUREG · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · PROMACTA · Perjeta · Phesgo · Prolia · RETEVMO · Revlimid · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYLVANT · Stivarga · TAGRISSO · Truqap · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xtandi · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $4,144 per 100 Medicare services performed
Looking for a hematology & oncology in Delray Beach?
Compare hematology & oncologys in the Delray Beach area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
62
Per 100K population
4.1
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Segota is a clinical cardiology specialist, with moderate Medicare volume, and consulting-driven industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Segota experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Segota performed 83 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Segota receive payments from pharmaceutical companies?
Yes. Dr. Segota received a total of $15,499 from 43 companies across 234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Segota's costs compare to other hematology & oncologys in Delray Beach?
Dr. Segota's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Segota) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →